Perkins Capital Management Inc. cut its stake in shares of NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 1.3% in the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 193,950 shares of the medical research company’s stock after selling 2,550 shares during […]
Emerald Advisers LLC raised its stake in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) by 16.4% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,927,074 shares of the medical research company’s stock after acquiring an additional 270,855 shares during the period. NeoGenomics comprises about […]
Needham & Company LLC reiterated their buy rating on shares of NeoGenomics (NASDAQ:NEO – Free Report) in a research report sent to investors on Thursday morning, Benzinga reports. The brokerage currently has a $21.00 price target on the medical research company’s stock. Other equities research analysts also recently issued research reports about the company. StockNews.com […]
NeoGenomics, Inc. (NASDAQ:NEO – Get Free Report) shares gapped down before the market opened on Thursday . The stock had previously closed at $20.50, but opened at $18.05. NeoGenomics shares last traded at $17.43, with a volume of 713,161 shares traded. Wall Street Analyst Weigh In A number of research analysts have recently weighed in […]
NeoGenomics, Inc. (NASDAQ:NEO) Receives Average Recommendation of "Moderate Buy" from Analysts theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.